Original Source(s)
Related Content
AI Scribes: Efficiency for Whom?
Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.
January 27, 2026
-
3 min
FDA Approves Pediatric Risankizumab
Approval expands risankizumab use to pediatric plaque psoriasis and psoriatic arthritis and includes a new 55-mg prefilled syringe for weight-based dosing in patients weighing less than 40 kg.
June 29, 2026
-
3 min
Medical Oddities: Ancient Practice Calms Modern BP
Ancient workouts, anxious ears, tea gains, limb regrowth, and furry tongues collide.
by Teraya Smith
May 13, 2026
-
5 min
